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Bile salts and bacteria have intricate relationships. The composition of the intestinal pool 
of bile salts is shaped by bacterial metabolism. In turn, bile salts play a role in intestinal 
homeostasis by controlling the size and the composition of the intestinal microbiota. 
As a consequence, alteration of the microbiome–bile salt homeostasis can play a role 
in hepatic and gastrointestinal pathological conditions. Intestinal bacteria use bile salts 
as environmental signals and in certain cases as nutrients and electron acceptors. 
However, bile salts are antibacterial compounds that disrupt bacterial membranes, 
denature proteins, chelate iron and calcium, cause oxidative damage to DNA, and con-
trol the expression of eukaryotic genes involved in host defense and immunity. Bacterial 
species adapted to the mammalian gut are able to endure the antibacterial activities 
of bile salts by multiple physiological adjustments that include remodeling of the cell 
envelope and activation of efflux systems and stress responses. Resistance to bile salts 
permits that certain bile-resistant pathogens can colonize the hepatobiliary tract, and an 
outstanding example is the chronic infection of the gall bladder by Salmonella enterica. 
A better understanding of the interactions between bacteria and bile salts may inspire 
novel therapeutic strategies for gastrointestinal and hepatobiliary diseases that involve 
microbiome alteration, as well as novel schemes against bacterial infections.
Keywords: bile salts, gall bladder, intestinal microbiome, gene regulation, resistance to bile, Salmonella, chronic 
infection
CONTRiBUTiON OF BACTeRiAL MeTABOLiSM  
TO THe iNTeSTiNAL POOL OF BiLe SALTS
Bile salts are produced in the liver from cholesterol, specifically in pericentral hepatocytes, and their 
daily production is approximately 350 mg (1). Seventeen enzymes convert cholesterol into bile acids, 
which are transformed into bile salts by the association with Na+ or K+ ions. There are four types of 
bile salts: primary and secondary, conjugated, and non-conjugated (2, 3). Conjugation involves the 
formation of an amide bond with either taurine or glycine.
Primary bile salts are the immediate products of cholesterol degradation. Variations in the pool 
of primary bile salts occur among vertebrates: for instance, in humans and rats, the primary bile salts 
are cholate and chenodeoxycholate while in mice they are cholate and muricholate (2). Intestinal 
bacteria transform primary bile salts into secondary bile salts by removal of the hydroxyl group 
at C7. In humans, secondary bile salts are deoxycholate (DOC, from cholate) and litocholate (from 
chenodeoxycholate) (4, 5). The hydroxyl groups of bile salts protrude in the same direction, a feature 
2Urdaneta and Casadesús Interactions between Bacteria and Bile Salts
Frontiers in Medicine | www.frontiersin.org October 2017 | Volume 4 | Article 163
that is partly responsible for their detergent activity because it 
confers high-water solubility and generates delimited hydrophilic 
and hydrophobic regions (6).
Intestinal anaerobes play a major role in bile salt metabolism 
(7, 8), and the main transformations are as follows:
 (i)  Hydrolysis of the amide bond between the glycine or the 
taurine conjugated to the steroid nucleus. This reaction, 
called deconjugation, makes bile salts available as substrates 
for further modifications by the intestinal microbiota and 
is, therefore, crucial in bile biotransformation (9–11). 
Deconjugation is catalyzed by bacterial enzymes known 
as bile salt hydrolases (BSH), which are widespread in 
the bacterial world and include Gram-positive intestinal 
species like Lactobacillus (12–16), Enteroccocus (17, 18), 
Bifidobacterium (19–21), and Clostridium (22). BSH 
activity has also been reported in the commensal, Gram-
negative Bacteroides spp. (23), and in the Archaea domain, 
specifically in species of the intestinal microbiome, such as 
Methanobrevibacter smithii and Methanosphera stadmanae 
(23). The high levels of identity found between BSH of 
different domains suggest horizontal gene transfer (23). 
Additionally, BSH genes show high redundancy in the 
gut ecosystem, and the number of BSH paralogs varies 
from strain to strain; for instance, in some serovars of 
Lactobacillus plantarum four different functional BSH 
genes have been described (13, 24). A potential selective 
value of BSH activity is enhancement of bile tolerance, thus 
facilitating survival in the gut (23, 25). Furthermore, bile 
salts serve as acceptors of electrons generated by fermenta-
tion while glycine and taurine can be used as sources of 
carbon and nitrogen (6).
 (ii) 7α/β-dehydroxylation converts primary bile salts into sec-
ondary bile salts. Examples are 7α-dehydroxylation of cholate 
and chenodeoxycholate yielding deoxycholate and lithocho-
late, respectively, and 7β-dehydroxylation of ursodeoxycho-
late yielding lithocholate (11). These biotransformations 
occur in the human colon, and deoxycholate and lithocho-
late are the predominant bile salts in human feces (7, 26). 
A pre-requisite for these transformations is deconjugation 
because 7α/β-dehydroxylation occurs in free bile salts (27). 
Unlike BSH activity, only a small number of bacterial species 
belonging to the class Clostridia have 7α/β-dehydroxylation 
activity (28). Transformation of primary into secondary bile 
salts requires transport of free primary bile salts into the 
bacterial cell, which is carried out by the proton-dependent 
bile acid transporter BaiG (29). Once inside the cell, a series 
of reactions occur, beginning with ligation of the bile salt 
to CoA in a Mg2+- and ATP-dependent reaction catalyzed 
by CoA ligase (30). The bile salt-Coa thioester is then 
oxidized at the 3-hydroxy group by a 3α-hydroxysteroid 
dehydrogenase (31). After oxidation, NAD-dependent fla-
voproteins synthesize 3-dehydro-Δ4-chenodeoxycholate or 
3-dehydro-Δ4-cholate and 3-dehydro-Δ4-ursodeoxycholate, 
respectively (31, 32), making the bile salt chemically labile 
for irreversible 7α-dehydration (7). The enzymes involved 
in further steps of this pathway have not yet been identified; 
they may include oxidoreductases that catalyze reduc-
tion to secondary bile salts (7). A potential advantage for 
7α/β-dehydroxylating bacteria might be favorable niche 
competition upon exclusion of microorganisms sensitive to 
secondary bile salts (7); additionally, production of reduced 
NADPH might be energetically useful by providing proton 
motive force (9).
 (iii) Numerous enteric especies (e.g., Clostridium, Peptostrep­
tococcus, Bacteroides, Eubacterium, and Escherichia coli) can 
perform oxidation and epimerization of hydroxy groups 
at the positions C3, C7, and C12 of bile salts, generating 
isobile (β-hidroxy) salts. Examples are 3-oxocholanoate 
and isocholate; 7-oxocholanoate and 7-epicholate; and 
12-oxocholanoate and 12-epicholate (11). Oxidation and 
epimerization are catalyzed by hydroxysteroid dehydroge-
nase. Epimerization is a reversible stereochemical change 
from α to β configuration or vice versa, with the formation 
of a stable oxo-bile salt intermediate (7). These modified bile 
salts (epimers and isobile salts) are usually recycled to the 
liver and repaired before rejoining bile (9).
Some of these biotransformations contribute to the salvage 
of bile salts that escape active transport in the distal ileum dur-
ing enterohepatic circulation. Particularly, deconjugation and 
7α-dehydroxylation increases hydrophobicity and Pka of bile 
salts, facilitating their recovery by passive transport in the colon 
epithelium (7).
In the absence of microbial transformations, the diversity of 
the bile salt pool decreases (33). The intestinal microbiota has 
an active role in the regulation of bile salt synthesis: bacterial 
metabolism decreases the level of taurine-conjugated muricholic 
acid, a farnesoid X receptor (FXR) antagonist that inhibits FXR 
signaling in the intestine. FXR signaling reduces the expression 
of cholesterol 7α-hydrolase (CYP7a1), a rate-limiting enzyme 
in bile acid synthesis; and as a consequence, primary bile acid 
synthesis is reduced. Hence, the gut microbiota regulates not 
only secondary bile salt metabolism but also primary bile salt 
synthesis by alleviating FXR inhibition (34).
Figure  1 depicts the process of synthesis of the most 
abundant bile salts present in human bile and their circulation 
trough the hepatic, biliary, and digestive systems, as well as 
their chemical structure and physicochemical properties.
MODULATiON OF THe GUT MiCROBiOMe 
BY BiLe SALTS
The human body is a complex ecosystem where the number of 
commensal bacterial cells are roughly as abundant as “human” 
cells (36). Particularly, the gut microbiome has one of the highest 
bacterial densities in nature (1012 bacteria/g feces, wet weight) 
(7, 37), and may be viewed as a dynamic community that has 
co-evolved with their host to facilitate digestion and absorption 
of complex food components (38). In this symbiotic process, the 
host must control bacterial colonization of the small intestine 
since bacterial overgrowth can lead to deficient absorption of 
nutrients due to bacterial competition with the host.
FiGURe 1 | (A) Synthesis of the major bile acids of human bile and circulation in the hepatic, biliary, and digestive systems. Bile acids are transformed into bile salts 
by the association with Na+ or K+ ions. Primary bile acids are stored in the gall bladder. After food ingestion, bile released into the small intestine contains 5–15 g of 
bile acids. In the intestine, bile acids are modified by the effect of intestinal microbiota. Both primary and secondary bile acids are reabsorbed in the terminal ileum 
into the blood stream. Modified from Fontana et al. (3). (B) Bile acids can be conjugated with either glycine or taurine. In this example, cholic acid becomes either 
taurocholic acid or glycocholic acid after conjugation with taurine or glycine, respectively. (C) Bile acids are amphipathic, and their hydrophobic side associates with 
the surface of lipid droplets while the polar groups interact with water creating a stable emulsion of small, mixed micelles. Modified from Hofmann (5) and Vander 
et al. (35).
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The factors that can induce changes in the gut microbiome 
include transit time, abundance of proteolytic enzymes, anti-
microbial peptides, diet, age, antibiotic use, disease, and bile 
(7, 39, 40). Several studies have reported the effect of bile salts on 
gut microbial communities. According to Kakiyama et al. (40), 
there is a connection between liver health, bile composition, and 
gut microbiome structure: as an example, patients with cirrho-
sis exhibit lower levels of fecal bile salts, which reflects a drop 
in conversion of primary to secondary bile salts. This decrease 
may be correlated with an alteration of the gut microbiome 
upon overgrowth of enteric bacteria (potential pathogens) and 
decreased abundance of 7α-dehydroxylating Gram-positives like 
Lachnospiraceae, Ruminococcaceae, and Blautia. On the other 
hand, the amount of bile released into the intestine can alter 
gut colonization: a low level of bile salts favors proliferation of 
Gram-negative bacteria (including pathogens), while high levels 
of bile salts favors the proliferation of Gram-positive bacteria and 
reduction of the Gram-negative Bacteroides (41).
High-fat diets, characteristic of Western populations, also 
affect the structure of the intestinal microbiome by altering the 
bile salt pool (42, 43). Experiments carried out with an animal 
model for inflammatory bowel disease (interleukin-10-deficient 
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mice), have shown that the gut microbiome community is altered 
when the animals are fed with a high saturated fat diet. In par-
ticular, the authors detected proliferation of the sulfite-reducing 
pathobiont Bilophila wadswortia (42), a bacterial species that 
is difficult to detect in healthy organisms but is associated with 
appendicitis and intestinal inflammation (44, 45). A diet high 
in saturated fat favors taurine conjugation of bile salts over 
glycine conjugation, increasing organic sulfur availability for 
B. wadswortia (43).
Bile participates in maintaining the intestinal homeostasis as 
an activator of the FXR and of the Vitamin D nuclear receptor 
(VDR) (45–48). FXR is a transcription factor from the nuclear 
receptor family and functions as the main sensor of intracellular 
bile levels. It is most abundant in tissues exposed to bile salts 
like the liver and the intestine (49, 50) and modulates intestinal 
innate immunity (49). The role of FXR in antibacterial defense 
was inferred from the observation that mice with obstructed 
bile ducts suffered from microbial proliferation followed by 
invasion of the epithelium; these symptoms were alleviated by 
either a synthetic FXR ligand or by bile salts (46, 47, 51). FXR 
activates genes involved in enteric protection and inhibition 
of bacterial overgrowth like the angiogenin gene Ang1 and the 
nitric oxide synthase gene iNos (46, 50). Furthermore, bile salts 
can induce the synthesis of cathelicidin in biliary epithelial cells. 
Cathelicidins are antimicrobial peptides that prevent bacterial 
infections in  vivo (51) including those caused by pathogenic 
E. coli (52) and are involved in innate immunity (53). Bile salts 
induce the extracellular protein kinase (ERK 1/2) pathway which 
in turn activates the VDR receptor, resulting in cathelicidin 
synthesis (48).
ALTeRATiON OF THe MiCROBiOMe-BiLe 
SALT HOMeOSTASiS iN HePATiC AND 
iNTeSTiNAL DiSeASeS
Because bile salts control the structure of the intestinal micro-
biome and the microbiome regulates the composition and size 
of the bile salt pool, alteration of the microbiome–bile salt 
homeostasis can have multiple pathological consequences. 
In cirrhotic patients, for instance, a shrinking bile salt pool 
may alter the intestinal microbiome by increasing the size of 
bacterial populations that produce proinflammatory molecules, 
which trigger a feedback loop as inflammation downregulates 
bile acid synthesis in the liver (54, 55). As cirrhosis progresses, 
decreased concentrations of bile salts in the small intestine 
permit bacterial overgrowth, which many contribute to cir-
rhosis complications like intestinal endotoxemia and hepatic 
encephalopathy (54, 56). Microbiome-induced alteration of the 
bile salt pool may also play a role in non-alcoholic fatty liver 
disease by impairing the activity of bile salt receptors and bile 
salt transporters (57).
Bile salt metabolism and signaling is also impaired in chol-
estasis, which causes accumulation of bile salts in the liver with 
concomitant hepatocyte injury and inflammation. Patients with 
chronic cholestasis may be at higher risk of developing hepatocel-
lular and bile duct cancer (58). This hypothesis is consistent with 
the observation that bile salts can promote cell proliferation by 
activating mitogenic pathways in the hepatobiliary tract (59).
The composition of the intestinal microbiota may also play 
a role in progression of colorectal cancer (58), and alteration 
of the composition of bile salt pool may be indirectly involved 
in this condition by favoring intestinal colonization by 
Firmicutes and Proteobacteria with concomitant decrease of 
Bacteriodetes (60).
In the stomach, alterations such as diet and drug use may 
favor the colonization of pathogens like Helicobacter pylori 
(61), which promotes mucosal inflammation of the gastric 
epithelium and has been identified as the strongest risk factor 
for gastric adenocarcinoma (62). In the particular case of adeno-
carcinomas associated with H. pylori-related proximal atrophic 
gastritis, an increase in concentration of bile salts in the distal 
stomach may prompt migration of the pathogen to the proximal 
stomach (63).
Other Helicobacter species have also been isolated from 
patients with biliary diseases like cholelithiasis, cholecystitis, gall 
bladder polyp, and gall bladder and biliary tract cancers (64–66).
BiLe SALTS AS eNviRONMeNTAL 
SiGNALS FOR iNTeSTiNAL BACTeRiA
The expression of certain bacterial loci is regulated by bile 
salts, which may serve as signals that identify the intestinal 
environment. For instance, Shigella invasion genes and certain 
Salmonella genes belonging to the PhoPQ regulon, which con-
trols multiple virulence traits, are upregulated in the presence 
of bile salts (67–69). In contrast, expression of the Salmonella 
enterica pathogenicity island 1 (SPI-1), which encodes a type 3 
secretion system necessary for invasion of the ileal epithelium, 
is inhibited by bile salts (70). This repression may prevent 
synthesis of invasion proteins in intestinal environments 
that are not appropriate for invasion. In Vibrio cholerae, bile 
salts activate transcription of genes involved in virulence and 
biofilm formation (71, 72). Changes in gene expression and/or 
protein synthesis in the presence of bile have been also 
described in the Gram-negative Campylobacter jejuni (73) and 
in the Gram-positives Enterococcus faecalis (74) and Listeria 
monocytogenes (75).
The molecular mechanisms involved in transcriptional regu-
lation by bile salts are known in certain cases. In Vibrio spp., 
bile salts bind specific receptors in the bacterial surface, 
activating signal transduction pathways that modulate gene 
expression patterns. For instance, the inner membrane proteins 
VtrA and VtrC of Vibrio parahaemolyticus are part of a bile 
salt-sensitive signal transduction system, and binding of bile 
salts to VtrC activates expression of type 3 secretion genes 
(76). Inner membrane proteins also control virulence gene 
expression in V. cholerae in response to bile salts: the TcpP/
TcpH and ToxR/ToxS pairs constitute bile salt-sensitive signal 
transduction systems that control transcription of toxT (77, 78). 
In turn, ToxR is a transcriptional activator of genes encod-
ing the cholera toxin and the toxin co-regulated pilus (79). 
In S. enterica, repression of invasion in the presence of bile salts 
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involves postranscriptional destabilization of the transcription 
factor HilD (80).
Bile salts also control pathogenesis of Clostridium difficile, a 
 Gram-positive spore-forming anaerobe (81). C. difficile vegeta-
tive cells produce enterotoxins (e.g., TccA and TcdB) that cause 
inflammation and diarrhea. This process is controlled by the 
cspBAC locus (82). Taurocholate, a conjugated primary bile 
salt, activates germination of the spores through interaction 
with the spore receptor CspC (83). Interestingly, the secondary 
bile salt deoxycholate can also promote spore germination but 
inhibits vegetative growth (84). On the other hand, chenode-
oxycholate, an unconjugated primary bile salt, inhibits spore 
germination and is a competitive inhibitor of taurocholate (85). 
Mice treated with broad spectrum antibiotics show increased 
susceptibility to C. difficile infection if their pools of secondary 
bile salts are diminished (86). These observations suggest that 
the type of bile salt predominant in the medium serves as an 
environmental signal to either remain dormant or trigger spore 
germination.
In enterohemorrhagic E. coli O157:H7, bile reduces the 
expression of genes of the enterocyte effacement (LEE) patho-
genicity island (87). When the concentration of bile decreases in 
downstream regions of the intestine, the LEE locus is activated. 
LEE expression induces attaching and effacing pathogenesis, 
and ultimately results in loss of the intestinal epithelial barrier 
(88). This pathology, which occurs specifically in the large intes-
tine, provides another example of bile salt-mediated intestinal 
signaling (87).
BiLe SALTS AS ANTiMiCROBiAL 
AGeNTS
Bile inhibits bacterial growth (69). In patients with primary cir-
rhosis, where biliary tract sterility is disrupted (89), the adminis-
tration of bile salts decreases endotoxin accumulation in biliary 
epithelial cells (90). The inhibitory effect of bile salts on bacterial 
growth can be also observed under laboratory conditions, and 
appears to be the consequence of multiple injuries caused by salts 
to the bacterial cell.
Disruption of Bacterial Cell Membranes
Bile acids are surface active, amphipathic molecules, and 
their detergent activity damages cell membranes. Not surpris-
ingly, many bile-sensitive mutants of both Gram-negative and 
Gram-positive bacteria carry mutations that impair membrane 
integrity. Likewise, electron microscopy studies have described 
a shrunken phenotype in Propionibacterium freudenreichii cells 
exposed to bile (91). Enzymatic assays in E. coli, Clostridium 
perfringens, and Lactobacillus acidophilus have shown that bile 
causes leakage of intracellular material (92, 93). Factors that 
influence the severity of membrane disruption are as follows:
 (i)  Concentration of bile, high concentrations will dissolve 
membrane lipids, causing leakage and cell death (94). Low 
concentrations of bile may have more subtle effects on mem-
brane fluidity and permeability by altering membrane-bound 
proteins or increasing trans-membrane divalent cation flux. 
Low levels of bile can also alter the hydrophobicity of the 
cell surface (92, 93, 95, 96).
 (ii)  Type and structure of bile salts. Bile salts conjugated with 
taurine or glycine are fully ionized at physiological pH and 
for this reason they remain in the outer hemi-leaflet of the 
membrane; on the contrary, unconjugated bile salts passively 
cross membranes and enter the cell (97–99).
 (iii) Membrane architecture and composition. Changes in 
lipopolysaccharide (LPS), membrane electric charge, hydro-
phobicity, lipid fluidity, and fatty acid composition alter bile 
resistance levels in multiple bacterial species (e.g., E. coli, 
L. monocytogenes, and L. acidophilus) (100–103).
induction of Macromolecular instability: 
DNA Damage
Upon entry into the bacterial cell, bile salts cause nucleic acid 
damage. In E. coli, sodium chenodeoxycholate and sodium deox-
ycholate activate the SOS response (104). Increased transcription 
of the SoxRS regulon genes osmY and micF suggests that DNA 
oxidative damage may occur upon exposure to bile salts (105, 106). 
In S. enterica, bile increases the frequency of nucleotide substi-
tutions, frameshifts, and chromosomal rearrangements (107), 
and the mutational spectrum of bile suggests that one primary 
lesion may be oxidative damage of cytosine (108). Bile salts 
also induce curing of the Salmonella virulence plasmid (109), 
a feature common among DNA damaging agents (110).
Misfolding and/or Denaturation of Proteins
The detergent activity of bile salts can alter the conformation of 
proteins. Not surprisingly, synthesis of chaperones DnaKJ and 
GroESL (91, 111), which assist in proper folding of proteins, 
increases in the presence of bile salts.
Chelation of iron and Calcium
Bile salts are able to chelate iron and calcium. In the case of 
iron, the primary bile acids taurocholic and glycocholic can 
form soluble Fe2+–bile salt complexes. This binding increases 
intestinal iron uptake (112). Because both the host and the 
microbiota require iron for fundamental cellular processes, bile 
salts may withhold iron from microorganisms, limiting their 
growth (113).
Calcium ions (Ca2+) can bind to micelles of bile salts conju-
gated with either taurine or glycine. This binding reduces Ca+2 
precipitation, thereby decreasing the contribution of calcium 
to the formation of gallstones (114). Calcium is also a signal 
involved in motility, cell cycle and cell division, control of gene 
expression, and chemotaxis (115, 116). Hence, shortage of Ca2+ 
upon bile salt chelation may also limit bacterial proliferation.
ReSiSTANCe TO BiLe iN eNTeRiC 
BACTeRiA
The ambivalent nature of bile salts as signals of the host environ-
ment and as antibacterial agents requires that intestinal bacteria 
can cope with bile-induced injuries. Not surprisingly, bacterial 
TABLe 1 | Genetic loci that contribute to bile resistance in enteric bacteria.
Gene Function of encoded 
protein(s)
Phenotype of 
mutants
Reference
phoPQ Two-component system Bile sensitive (69, 119)
marRAB Regulatory genes Bile sensitive (120)
acrAB Efflux pump Bile sensitive (119–121)
tolQRA,  
tolC
Cell envelope Bile sensitive (119, 122)
dam DNA adenine methylase Bile sensitive (107, 119, 123)
wecD,  
wecA
Biosynthesis and  
assembly of enterobacterial 
common antigen
Bile sensitive (124)
xthA  
and nfo
Exonuclease and  
endonuclease, respectively, 
involved in DNA repair
Bile sensitive (108)
recA, B,  
C, D, J
Repair and maintenance  
of DNA
Bile sensitive (108)
dinB DNA repair Bile sensitive (108)
seqA GATC-binding protein Bile sensitive (119, 125)
hupA DNA-binding protein Bile sensitive (119)
mrcA,  
mrcB
Penicillin-binding  
proteins 1A and 1B
Bile sensitive (119)
sanA Uncharacterized  
membrane protein
Bile sensitive (119)
sbcB Exonuclease, involved  
in DNA repair
No phenotype, locus 
upregulated by bile
(108)
yciF Unknown function No phenotype, locus 
upregulated by bile
(126)
STM4242 Unknown function No phenotype, locus 
upregulated by bile
(126)
rpoS General stress response Bile sensitive, locus 
upregulated by bile
(127)
prc Peptidoglycan remodeling Bile-hyperesistant (128)
rfa Lipopolysaccharide synthesis Bile-hyperesistant (117, 129)
toxR, toxT Regulatory genes Bile sensitive (130)
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species adapted to the mammalian intestine are resistant to bile 
salts, a trait exploited for the design of selective microbiological 
media such as the MacConkey agar used in the identification of 
genera of the family Enterobacteriaceae.
Addition of ox bile or individual bile salts to microbiological 
media is also a strategy to study resistance to bile salts under 
laboratory conditions. Using this reductionist approach, 
genetic and biochemical analyses have identified cell functions 
and mechanisms involved in bile resistance in a number of 
species including the model organisms E. coli and S. enterica  
(25, 117, 118) (Table  1). An overall conclusion from these 
studies is that resistance to bile involves multiple cell functions 
and mechanisms.
Bacterial Cell envelope
The cell envelope of Gram-negative bacteria contains three 
layers: the cytoplasmic (inner) membrane, the peptidoglycan 
cell wall, and the outer membrane. The outer membrane is 
asymmetrical: its inner leaflet consists mainly of phospholipids 
while the outer leaflet is almost entirely composed of a glycolipid 
known as LPS (131). Loss of the O-antigen in the LPS results in 
decreased resistance to bile (117, 129); on the contrary, very long 
O-antigen chains increase bile resistance (132). The relevance of 
the LPS structure in bile resistance is further supported by the 
observation that S. enterica mutants hyper-resistant to bile often 
carry mutations in LPS transport genes (127).
Another cell envelope component that contributes to bile 
resistance is the enterobacterial common antigen (ECA), 
a family-specific glycolipid present in the outer leaflet of the outer 
membrane. In S. enterica, mutations in genes involved in ECA 
synthesis cause bile sensitivity (124).
Bile salts also induce peptidoglycan remodeling, and remod-
eling increases bile resistance. Growth of S. enterica in the pres-
ence of a sublethal concentration of DOC is accompanied by a 
reduction in the amount of Braun lipoprotein (Lpp) anchored 
to peptidoglycan (133). Because Lpp-containing muropeptides 
provide covalent linkage between the outer membrane and the 
peptidoglycan layer, reduction of this union may increase flex-
ibility in the cell envelope, perhaps altering outer-membrane 
fluidity. Growth of S. enterica in the presence of DOC is also 
associated with a decrease in 3–3 crosslinks between the sugar 
components of peptidoglycan (N-acetylmuramic acid and 
N-acetylglucosamine), suggesting that low crosslinking may 
increase bile resistance (133).
efflux Pumps
Even though the bacterial envelope provides a barrier that 
reduces bile salt uptake, bile salts can enter the cell by diffusion 
or by passage through porins like OmpF. As a consequence, 
active efflux is necessary to reduce their concentration inside 
the cell (134). Among the efflux systems found in enterobacte-
rial species, AcrAB–TolC is the best characterized (135–138). 
It comprises the outer-membrane protein channel TolC, the 
proton force-dependent transporter AcrB located in the inner 
membrane, and the periplasmic protein AcrA, which aids in 
efflux by bridging the TolC and AcrA integral membrane pro-
teins (139). The AcrAB–TolC efflux pump is able to transport a 
diverse array of compounds with little chemical similarity (140), 
and is essential for bile resistance (120, 121, 141, 142). The genes 
encoding the AcrAB–TolC multidrug efflux system are under 
the control of a transcriptional regulator known as RamA. In 
turn, transcription of the ramA gene is activated by bile salts, 
mainly by relieving transcriptional repression exerted by the 
RamR protein (138, 143).
DNA Repair Mechanisms
DNA adenine methylase (Dam–) mutants of S. enterica are bile 
sensitive (123, 144), and genetic analysis unveils the involvement 
of Dam-directed mismatch repair (107): mutations in any of the 
mismatch repair genes mutH, mutL, or mutS suppress bile sen-
sitivity in dam mutants, providing evidence that bile sensitivity 
is caused by MutHLS activity. Salmonella MutHLS− mutants are 
not sensitive to bile, indicating that bile-induced DNA damage 
can be repaired by mechanisms other than Dam-dependent 
mismatch repair. In Dam− mutants, however, lack of DNA strand 
discrimination causes DNA strand breakage when the MutHLS 
systems deal with bile-induced lesions (107).
Surveys of bile sensitivity among S. enterica DNA repair 
mutants have revealed that base excision repair (BER), SOS-
associated DNA repair, and recombinational repair by the 
RecBCD enzyme are required to cope with bile-induced DNA 
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damage (108). In contrast, nucleotide excision repair (NER) is 
dispensable. The observation that bile resistance requires BER but 
not NER suggests that bile-induced DNA lesions are unlikely to 
be bulky, thus providing indirect support for the occurrence of 
oxidative damage (107, 108).
Several lines of evidence suggest that bile salts may impair 
DNA replication in Salmonella: (i) dinB mutations confer bile 
sensitivity, suggesting that SOS-associated translesion DNA 
synthesis may be required to overcome bile-induced DNA dam-
age; (ii) RecB–, RecC–, and RecA− RecD− double mutants are 
also bile sensitive, indicating that survival to bile may require 
RecB-dependent homologous recombination (108). A tentative 
scenario is that primary lesions (e.g., oxidized cytosine moie-
ties) may trigger BER. As a consequence, BER exonucleases will 
produce DNA strand breaks as an intermediate step in the DNA 
repair process. Furthermore, as indicated above, DNA strand 
breaks can also be formed as a consequence of MutHLS activ-
ity. These DNA strand breaks may impair progression of DNA 
replication forks, inducing the SOS response (see below); as a 
consequence, DinB-mediated translesion DNA synthesis may 
occur (108). It is also conceivable that bile-induced lesions could 
directly block DNA replication, thus inducing the SOS response 
in a direct fashion. In such a scenario, the need of homologous 
recombination mediated by the RecBCD enzyme complex might 
reflect the occurrence of stalled DNA replication forks (108).
Stress Responses
Given the multiple injuries caused by bile salts to the bacterial 
cell, it is not surprising that stress regulons are induced in the 
presence of bile. The relevance of the DNA damage responsive 
SOS regulon, mentioned already in the previous section, is 
supported by the observation that LexA(Ind–) mutants, which 
are unable to induce the SOS response, are bile sensitive (108). 
Somehow surprisingly, the oxidative damage-responsive OxyR 
and SoxRS regulons, which are also activated by bile salts, are not 
essential for bile resistance (108). A tentative explanation is that 
redundance may exist in the stress responses of the bacterial cell 
so that certain functions can be backed up by others.
The RpoS-dependent general stress response is essential for 
bile resistance, and RpoS− mutants are bile sensitive. In S. enterica, 
an interesting feature of the RpoS response is inhibition of 
con jugation in the presence of bile, which involves post trans-
criptional control of rpoS mRNA and ricI mRNAs by the small 
regulatory RNA RprA (145). The ricI gene encodes a cyto plas-
mic membrane protein that inhibits plasmid transfer by direct 
inter action with the conjugation apparatus protein TraV. 
RpoS− mutants of S. enterica are avirulent in the mouse model of 
typhoid (146, 147), and it seems reasonable to hypothesize that 
one cause of avirulence may be bile sensitivity.
Transcriptomic analysis has identified additional, RpoS-
independent stress-inducible genes that increase their expression 
in the presence of DOC (cspD, uspA, aphC, etc.) (127). Although 
the contribution of these loci to bile resistance remains to be 
established, the number and variety of stress functions activated 
by bile salts supports the view that multiple stress responses 
contribute to bile resistance. Some such responses appear to be 
essential while others are not.
COLONiZATiON OF THe HePATOBiLiARY 
TRACT BY Salmonella enterica
Salmonella stands out among bile-resistant bacterial genera 
because of its ability to colonize the hepatobiliary tract causing 
chronic infection. The current taxonomy defines six subspecies 
of S. enterica, which are in turn classified into serovars. The 
majority of serovars belong to subspecies enterica (148), which 
colonizes warm-blooded vertebrates (149) and accounts for 99% 
of human infections by Salmonella (150). Serovars belonging to 
subsp. enterica differ in host specificity and in the type of disease 
they produce. Some serovars are host-restricted, while others can 
infect a wide variety of animal hosts (151).
Figure  2 depicts the biology of Salmonella infections in 
humans. All diseases start upon invasion of the intestinal 
epithelium, often through M cells. Translocation across the 
intestinal epithelium is mediated by the virulence-associated 
type 3 secretion system encoded by Salmonella pathogenicity 
island 1 (SPI-1) (152), and invasion allows the bacteria to reach 
lymphocytes B and T below Peyer patches (153). Once the epi-
thelium is crossed, S. enterica can produce three main types of 
infection: gastroenteritis, systemic infection, and asymptomatic 
chronic carriage.
 (i)  Gastroenteritis, a self-limited infection of the terminal 
ileum and colon which is the most common Salmonella 
infection worldwide, with more that 90 million cases per 
year (158). Gastroenteritis is produced by typhoidal sero-
vars, especially Typhimuriun and Enteritidis. A localized 
inflammatory response induces infiltration of polymor-
phonuclear leukocytes, which helps to contain bacterial 
dissemination beyond the intestinal submucosa. Secretion 
of fluids and electrolytes in the small and large intestines 
produces diarrhea.
 (ii) Systemic infection is produced by Salmonella serotypes 
that invade intestinal macrophages and disseminate inside 
the organism trough the lymphatic system, permitting 
colonization of internal organs such as the liver, the 
spleen, the bone marrow, and the gall bladder (Figure 2). 
In humans, typhoid and paratyphoid fever are caused by 
serotypes Typhi and Paratyphi, respectively. These infec-
tions are associated with high morbidity and mortality 
rates (159). Typhoid fever is estimated to cause over 20 
million illnesses and over 200 thousand deaths worldwide, 
while the number of cases of paratyphoid fever is estimated 
over 5 million (160).
 (iii) Chronic carriage. A fraction of individuals recovering from 
typhoid fever become asymptomatic, life-long carriers of 
S. Typhi. Non-typhoidal Salmonella serovars can also cause 
persistent infections, either associated with cholecystitis or 
asymptomatic, although the duration of carriage is usually 
limited to several months. The mesenteric lymph nodes, the 
liver, and the gall bladder appear to be the main Salmonella 
reservoirs during chronic carriage (161).
Colonization of the gall bladder by Salmonella in asymptomatic 
carriers permits shedding of Salmonella cells into the intestine 
FiGURe 2 |  Salmonella enterica infection pathogenesis. (1) Salmonella infection starts with the ingestion of contaminated food or water. (2) Salmonellae invade 
intestinal epithelial cells and migrate to the lamina propria. (3) Two types of infection can occur: gastroenteritis and systemic infection. (4) During systemic 
dissemination, Salmonella colonizes the liver, the spleen, and the bone marrow. (5) From the liver, Salmonella reaches the gall bladder and can cause chronic 
carriage. (6) Salmonella carriers shed bacteria into the small intestine upon secretion of bile, and feces contain Salmonella cells. Inspired from Ref. (154–157).
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upon gall bladder contraction, with concomitant release of bile. 
From the small intestine, the bacteria travel downwards in the 
gut, ultimately being released with feces (153, 155). Aside from 
its epidemiological implications, chronic Salmonella carriage 
may predispose to gall bladder cancer, mainly as a consequence 
of chronic cholecystitis (162–164).
The bacterial lifestyle in the gall bladder is one of the less 
known aspects of Salmonella biology and a fascinating scientific 
conundrum. How is it possible that the high concentration of 
bile salts present in the gall bladder permits Salmonella sur-
vival? How is it possible that Salmonella survival in such a harsh 
environment can last for a lifetime? Answers to these questions 
are not simple; survival of Salmonella in the gall bladder appears 
to involve several adaptive strategies, which may be perhaps 
simultaneously adopted by subpopulations as a bet hedging 
strategy.
 (i)  A fraction of the Salmonella population may escape from 
bile salts by invasion of the gall bladder epithelium in a SPI-
1-dependent manner, followed by replication in a vacuole 
(165). In this situation, extrusion of infected epithelial cells 
and release of Salmonella cells into the lumen has been 
observed. According to Gonzalez-Escobedo and Gunn 
(166), this mechanism could be important in maintaining 
the chronic carrier state and dissemination, because the 
bacteria released could either re-infect the epithelium or be 
shed into the medium.
 (ii)  Gallstones may play a major role in chronic infection. 
Using a murine model of typhoid carriage, John Gunn and 
co-workers have provided evidence that S. Typhimurium 
can form biofilms on the surface of cholesterol gallstones. 
The biofilm matrix provides high resistance to antimicrobial 
agents (167, 168), thereby explaining why antibiotic therapy 
is ineffective in carriers of S. enterica serovar Typhi who suf-
fer from gallstone formation (169). This view is supported 
by the fact that S. typhi cells are detected on gallstones from 
human typhoid carriers (169).
 (iii) Planktonic Salmonella cells can multiply in the gall bladder 
lumen, presumably using phospholipids as carbon and 
energy sources (170). How these unprotected cells endure 
the bactericidal activities of bile remains unknown. A tenta-
tive speculation is that activation of bile-responsive stress 
responses may generate cell lineages in which resistance to 
bile is maintained by feedback loops that are transmissible 
through cell division. In addition, bile-resistant mutants 
may appear, especially during longtime colonization as bile 
salts are mutagenic (108).
CONCLUDiNG ReMARKS AND FUTURe 
PeRSPeCTiveS
The composition of the bile salt pool is shaped by bacterial 
metabolism, and bile salts are used as physiological signals by 
both bacteria and hepatic cells. This entangled relationship is 
made even more complex by the fact that bile salts are antibacte-
rial agents. A better understanding of the contribution of the bile 
salt pool to gastrointestinal and hepatobiliary homeostasis may 
inspire novel therapeutic strategies for conditions that involve 
microbiome alteration (e.g., cirrhosis, fatty liver disease, cholesta-
sis, colorectal cancer, and certain types of Helicobacter-associated 
cancer). In turn, knowledge of mechanisms of bile resistance in 
intestinal pathogens may stimulate novel schemes to combat 
infectious diseases. For instance, eradication of Salmonella Typhi 
from the gall bladder of chronic carriers by procedures other 
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